Brief: BioAtla Q4 Net Income USD -26.925 Million
26/03/2024 20:01
Mar 26 (Reuters) - BioAtla Q4 operating expenses USD 28.536 million. * Q4 operating income USD -28.536 million
Recent news on Bioatla
See all newsBrief: Context Therapeutics Enters Into License Agreement Amendment With BioAtla For CT-202
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM